Approval · Notice of Compliance 20841 · 2018
HADLIMA: Notice of Compliance 20841
Issued May 8, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20841
- Date
- May 8, 2018
- Company
- Samsung Bioepis Co., LtdIncheon, Incheon, Korea, Republic Of
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HADLIMA | 02473097 | Marketed |
| HADLIMA PUSHTOUCH | 02473100 | Marketed |
Medicinal ingredients
- ADALIMUMAB 40 MG per 0.8ML